Pharmiva AB (publ) (OM:PHARM) entered in the letter of intent to acquire PEPTONIC medical AB (publ) (NGM:PMED) on June 15, 2023. According to the Takeover rules for certain trading platforms, which are administered by the Swedish Stock Market Self-Regulation Committee, the rules also apply in the event of mergers and merger-like processes.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.06 SEK | -.--% | -.--% | +3.45% |
Apr. 17 | Peptonic Medical Plans SEK61 Million Shares, Warrants Issue | MT |
Apr. 15 | Peptonic Medical Secures US Patent for Vaginal Yeast Infections Treatment | MT |
1st Jan change | Capi. | |
---|---|---|
+3.45% | 8.4M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- PMED Stock
- News PEPTONIC medical AB
- Pharmiva AB (OM: PHARM) entered in the letter of intent to acquire PEPTONIC medical AB.